微生物のβ-CAをターゲットにすること:シリコスクリーニングとインビトロ検証の橋渡し
Anna Rita Tondo1, Marialuigia Fantacuzzi2, Simone Carradori3
1Department of Pharmacy and Pharmaceutical Sciences, University of Bari "A. Moro", Via Orabona 4, 70126 Bari, Italy.
Bioorganic & medicinal chemistry
|January 1, 2026
まとめ
No abstract available in PubMed .
さらに関連する動画
09:39A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
18.4K
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.4K
関連する概念動画
In Vitro Drug Release Testing: Overview, Development and Validation
600
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
600
Automated Microbial Diagnostics
83
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
83
